23 Nov Protocol registration – SGLT2 inhibitors decrease the risk of cardiovascular events in patients with type 2 diabetes Posted at 12:02h in by CNODES Admin Redirecting to Project: SGLT2 inhibitors and risk of major adverse cardiovascular events (Q18-06)
